ALA光动力通过募集天然淋巴样细胞重建皮脂腺稳态治疗痤疮的机制研究
批准号:
82103768
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
张海艳
依托单位:
学科分类:
皮肤病学研究新技术与新方法
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
张海艳
中文摘要
ALA光动力治疗重度痤疮安全有效,但机制尚未完全阐明。新近研究发现皮脂腺稳态失衡是痤疮的重要致病因素,稳态失衡的关键在于皮脂腺周围天然淋巴样细胞(ILCs)的缺失。本课题组前期研究ALA光动力治疗前、后重度痤疮临床样本的基因表达谱芯片时,意外发现治疗后多个ILCs相关标志物表达均显著上调,进一步通过动物实验确证光动力治疗后皮脂腺周围ILCs明显增多,结合最新研究提出科学假说:ALA光动力可能通过上调炎症因子募集ILCs,分泌TNFα/LTα,抑制皮脂腺细胞Notch信号通路,重建皮脂腺稳态,发挥痤疮治疗作用。本课题拟进一步应用临床样本、金黄地鼠痤疮模型及课题组前期自主构建的中国人永生化皮脂腺细胞系,从体内、细胞及分子水平探索ALA光动力治疗后ILCs的募集机制及其重建皮脂腺稳态的关键信号通路。本课题的完成有助于完善ALA光动力治疗痤疮的机制理论,为优化ALA光动力的临床应用提供新策略。
英文摘要
ALA photodynamic therapy(ALA-PDT)is safe and effective for severe acne, but the mechanism has not been fully elucidated. Recent studies have found that the imbalance of sebaceous gland(SG) homeostasis is an important pathogenic factor for acne. The key role of SG homeostasis imbalance is the loss of innate lymphoid cells (ILCs) around sebaceous glands. When analyzing the gene expression profile of clinical samples of severe acne before and after ALA-PDT in the previous research of our group, it was unexpectedly found that the expression of multiple ILCs-related markers were significantly up-regulated after treatment,and further animal experiments confirmed the ILCs increased significantly around sebaceous glands after ALA-PDT. Combined with the latest studies, a scientific hypothesis was put forward: ALA-PDT recruits ILCs by up-regulating inflammatory factors, secretes TNFα/LTα, inhibits the Notch signaling pathway of sebaceous gland cells, reconstructs SG homeostasis, and plays a role in acne treatment. This project intends to further use clinical samples, golden hamster acne model and the Chinese immortalized sebaceous gland cell line independently constructed by our own research group in the early stage to explore the recruitment mechanism of ILCs and the key signal pathway of SG homeostasis reconstruction after ALA-PDT at the in vivo, cellular and molecular levels. The completion of this topic will help improve the mechanism theory of ALA-PDT for acne, and provide a new strategy for optimizing the clinical application of ALA-PDT.
痤疮是一种常见的毛囊皮脂腺疾病,重度痤疮可形成瘢痕,病程反复,严重影响患者尤其是青少年的身心健康。本课题组在国内较早开展ALA-PDT治疗痤疮,发现其具有疗效好、美容效果好、无系统不良反应等优点,同时发现治疗前后皮脂腺分泌显著减少,重建了局部皮脂腺稳态。本项目成功构建小鼠痤疮样模型,构建人皮脂腺细胞系XL-i-20,通过体内体外实验进一步验证ALA-PDT治疗重度痤疮后通过促炎因子释放,募集局部天然淋巴样细胞ILC。ALA-PDT治疗痤疮安全有效,而其重建皮脂腺稳态的机制值得进一步研究。同时发现ALA-PDT可通过抑制 AKT 磷酸化促进 NR4A1 转录抑制皮脂合成及分泌,从而重建皮脂腺稳态治疗痤疮。本项目进一步提示皮脂腺稳态在痤疮发病转归中的重要性,进一步促进ALA-PDT的推广应用。
国内基金
海外基金